Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05593341 · ClinicalTrials.gov registry record · NA

Opioid Education in Total Knee Arthroplasty

A NA study of Postoperative Pain and Opioid Use, sponsored by Hospital for Special Surgery, New York.

Completed
Registry status
NA
Development phase
42
Enrollment target
1
Study location

NCT05593341: Completed NA study of Postoperative Pain and Opioid Use, sponsored by Hospital for Special Surgery, New York.

NCT05593341 is a NA study of Postoperative Pain and Opioid Use that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 42 participants, below the 231-participant average among 120 other Postoperative Pain trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05593341, a NA study of Postoperative Pain and Opioid Use, has completed, sponsored by Hospital for Special Surgery, New York.

COMPLETED
Registry status
NA
Development phase
42 participants
Enrollment target
1
Study location

Study Summary

The goal of this experimental study is to compare different education intervention on opioid education for patients undergoing total knee arthroplasty. The specific research questions to address are: 1. Does perioperative education pathway reduce opioid refill requests? 2. Is education pathway that focuses on pain management provided in-person and via video in repeated sessions more effective than current standard of care education consisting of a single exposure given as part of a broader preoperative presentation covering multiple topics? 3. Is there a difference between education provided in-person vs video? 4. Does perioperative education improve compliance with multimodal analgesia? 5. Does perioperative education improve appropriate opioid storage? 6. Does perioperative education improve appropriate opioid disposal? Enrolled patients will be assigned at random to one of 3 study groups. Group 1 (control): Patients are referred to the hospital's standard 1-hour virtual patient education webinar prior to surgery. Group 2 (in-person): Patients will receive two in-person education sessions (1st session before surgery and 2nd session after surgery). Patients will also receive portable document format (pdf) handouts about opioid and pain management. Group 3 (video): Patients will receive two video education sessions (1st session before surgery and 2nd session after surgery). Patients will also receive pdf handouts about opioid and pain management.

Primary Outcome

Patients will be asked if they have refilled their opioid prescription and the number of opioid refills.

Interventions

  • OTHER Opioid education in person
  • OTHER Opioid education via video

Study Locations (1)

New York

  • Hospital for Special Surgery - New York

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2022-09-27
Est. Completion 2023-09-11
Phase NA

What the finished NCT05593341 record still lists

NCT05593341 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 231-participant average among 120 other Postoperative Pain trials with a reported enrollment target (82% lower).

The record links to 5 conditions, with Postoperative Pain appearing as the primary indexed condition, and to 2 interventions - of which Opioid education in person is the first listed.

NCT05593341 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05593341 about?

NCT05593341 is a clinical study titled "Opioid Education in Total Knee Arthroplasty". The goal of this experimental study is to compare different education intervention on opioid education for patients undergoing total knee arthroplasty. The specific research questions to address are: 1. Does perioperative education pathway reduce opioid refill requests? 2. Is education pathway that...

What is the current status of trial NCT05593341?

This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2022-09-27. Estimated completion is 2023-09-11.

What conditions does trial NCT05593341 study?

This clinical trial studies the following conditions: Postoperative Pain, Opioid Use, Opioid Misuse, Opioid Abuse, Arthropathy of Knee.

What interventions are being tested in trial NCT05593341?

The interventions under investigation include: Opioid education in person (OTHER), Opioid education via video (OTHER).

Who is sponsoring clinical trial NCT05593341?

This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05593341 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postoperative Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05593341's enrollment target sits among peer trials

42 107th of 120 higher than 14 of 120 other Postoperative Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Postoperative Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02852213 · 42 participants · Phase 1

    A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients

  • NCT03136146 · 42 participants · Phase 2

    Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

  • NCT03178149 · 42 participants · Phase 1

    A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

  • NCT03663530 · 42 participants · NA

    Circadian Misalignment and Energy Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05593341, the US trial registry maintained by the National Library of Medicine. NCT05593341 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.